Companies / Sorrento Therapeutics, Inc.
Sorrento Therapeutics, Inc.
SRNESRNEQCIK 850261
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Sep 3, 2021 | Smith Robin L Director | Exercise Option exercise | Common Stock | $489.0K | +100K +74.07% | 235,000 | low |
| Sep 27, 2021 | Janda Kim Director | Sell Open-market sale | Common Stock | $339.7K | -42K -93.39% | 3,000 | medium |
| Sep 3, 2021 | Smith Robin L Director | Exercise Option exercise | Common Stock | $296.3K | +75K +125.00% | 135,000 | low |
| Sep 7, 2022 | Ji Henry Executive | Buy Open-market buy | Common Stock | $179.3K | +89K +1.90% | 4,765,805 | medium |
| Sep 6, 2022 | Ji Henry Executive | Buy Open-market buy | Common Stock | $108.9K | +56K +1.20% | 4,676,917 | medium |
| Aug 26, 2022 | Ji Henry Executive | Buy Open-market buy | Common Stock | $70.3K | +33K +1.60% | 2,121,362 | medium |
| Sep 13, 2021 | Janda Kim Director | Sell Open-market sale | Common Stock | $64.3K | -8K -72.73% | 3,000 | low |
| Sep 27, 2021 | Janda Kim Director | Exercise Option exercise | Common Stock | $63.0K | +35K +1166.67% | 38,000 | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| SRNE | common | 83587F202 |